How Humalog & Humalog Mixture Products Are Supplied
separetorPrinter Friendly Version
Humalog and Humalog Mixture insulins are supplied at a concentration of 100 units/mL.

Product Supplied Size Concentration Packaged NDC (Lilly Item Code)
Humalog
Rx ONLY		 Vial 10 mL 100
units/mL		 1 vial NDC 0002-7510-01
(VL-7510)
Humalog Cartridges
Rx ONLY		 Cartridge 3 mL cartridge 100
units/mL		 5 per package NDC 0002-7516-59
(VL-7516)
Original Humalog Prefilled Pen
Rx ONLY		 Prefilled insulin delivery device 3 mL pen 100
units/mL		 5 per package NDC 0002-8725-59
(HP-8725)
Humalog KwikPen™
Rx ONLY		 Prefilled insulin delivery device 3 mL pen 100
units/mL		 5 per package NDC 0002-8799-59
HumaPen®
MEMOIR™*
Rx ONLY		 Reusable insulin
delivery device		     1 pen UPC 0002-9660-01
HumaPen®
LUXURA™ HD*
Rx ONLY		 Reusable insulin
delivery device		     1 pen UPC 0002-9673-01
Humalog
Mix75/25
Rx ONLY		 Vial 10 mL 100
units/mL		 1 vial NDC 0002-7511-01
(VL-7511- 001)
Original Humalog Mix75/25 Prefilled Pen
Rx ONLY		 Prefilled insulin delivery device 3 mL pen 100
units/mL		 5 per package NDC 0002-8794-59
(HP-8794-059)
Original Humalog Mix50/50 Prefilled Pen
Rx ONLY		 Prefilled insulin delivery device 3 mL pen 100
units/mL		 5 per package NDC 0002-8793-59
(HP-8793)
Humalog Mix75/25 KwikPen™
Rx ONLY		 Prefilled insulin delivery device 3 mL pen 100
units/mL		 5 per package NDC 0002-8797-59
Humalog Mix50/50 KwikPen™
Rx ONLY		 Prefilled insulin delivery device 3 mL pen 100
units/mL		 5 per package NDC 0002-8798-59
* Used only with Humalog 3 mL insulin cartridges.

Information on packaging of insulin is also available at www.LillyDiabetes.com.



Important Safety Information
Humalog, Humalog Mix75/25, and Humalog Mix50/50 are for use in patients with diabetes to control high blood sugar. Humalog should be used with a longer-acting insulin, except when used in combination with sulfonylureas in patients with type 2 diabetes.

Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients. The safety and effectiveness of Humalog in patients less than 3 years of age have not been established. Safety and effectiveness of Humalog Mix75/25 and Humalog Mix50/50 in patients less than 18 years of age have not been established. There are no clinical studies of the use of Humalog insulins in pregnancy or nursing mothers.

Potential side effects associated with the use of all insulins include low blood sugar, weight gain, low blood potassium, changes in fat tissue at the site of injection, and allergic reactions, both general and local. Humalog Mix75/25 and Humalog Mix50/50 should not be mixed with another insulin. Starting or changing insulin therapy should be done cautiously and only under medical supervision.

Humalog insulins are available by prescription only. See the Humalog, Humalog Mix75/25, and Humalog Mix50/50 Patient Product Information for important facts about these products.

Humalog is a registered trademark of Eli Lilly and Company. Humalog Mix75/25 and Humalog Mix50/50 are trademarks of Eli Lilly and Company.



Humalog Patient Information | Humalog Mix75/25 Patient Information | Humalog Mix50/50 Patient Information | Important Safety Information